by Jordana Choucair | Jun 22, 2022 | Public Health/Prevention
The Senate cast a key vote to advance newly released bipartisan gun safety legislation. The legislation resulted from negotiations among 10 Republicans and 10 Democrats, and it is expected to have more than enough votes to overcome the 60-vote threshold to clear a...
by Jordana Choucair | Jun 21, 2022 | Life Sciences
The Centers for Disease Control and Prevention (CDC) recommended Saturday that children as young as 6 months old receive COVID-19 vaccines developed by Pfizer-BioNTech and Moderna. The move follows unanimous votes earlier from the CDC’s Advisory Committee on...
by Jordana Choucair | Jun 21, 2022 | Life Sciences
fizer agreed to invest $95 million to buy an 8.1 percent percent stake in French vaccines company Valneva. Pfizer and Valneva previously partnered to create a joint Lyme disease program, which is developing a Lyme disease vaccine candidate called VLA15. Valneva is...
by Jordana Choucair | Jun 21, 2022 | M&A
A UnitedHealth Group unit plans to acquire EMIS Group – a U.K. health technology company that focuses on primary care and pharmacy systems. UnitedHealth’s Optum UK executives said that the deal, valued at $1.5 billion, will bring more advanced technology...
by Jordana Choucair | Jun 21, 2022 | Payers
New research published in the Annals of Internal Medicine found that Medicare could have saved almost $4.0 billion if it were purchasing generic drugs directly from the Mark Cuban Cost Plus Drug Company (MCCPDC) online pharmacy. Specifically, Medicare could have saved...
Recent Comments